The Blood Cancer Center

At Siteman’s Blood Cancer Center, WashU Medicine physicians and scientists are advancing how we treat patients with a blood cancer diagnosis. Siteman is renowned for our breakthroughs in immunotherapy, where a patient’s own cells fight cancer. Our experts transform blood-forming stem cells and cells from the immune system into cellular therapies that bring patients lasting remissions and cures. 

Patients who are treated through the Blood Cancer Center benefit from a dynamic, research-focused environment.  We call this “bench to bedside” which means our physicians’ laboratory research often becomes part of their patients’ care. Many patients are enrolled in clinical trials that provide access to leading-edge therapies. 

The WashU Medicine physicians and specialists at the Blood Cancer Center collaborate on patient treatment plans. Our multi-disciplinary treatment teams include experts who are subspecialized as medical oncologists, radiation oncologists, surgeons, hematologists, transplant specialists, other specialized physicians and nurses. Every team member is excellent at coordinating both in-patient and out-patient care.  

What cancers are treated through the Blood Cancer Center?

The Blood Cancer Center at Siteman treats every form of blood cancer, including: 

When diagnosing a patient, our experts determine the exact type of blood cancer, so the treatment plan is specific to the sub-type. 

Leukemia

Siteman Cancer Center sees on average 265 new leukemia patients a year, many with AML, and are internationally recognized for their expertise.

Leukemia treatment
Woman's hands

Lymphoma

WashU Medicine physicians at Siteman Cancer Center treat an average of 325 new lymphoma patients a year, and are internationally recognized for their expertise.

Lymphoma treatment
Nurse_IV

Multiple Myeloma

Clinicians at Siteman Cancer Center see more than 300 new multiple myeloma cases a year and more other plasma cell neoplasms than most other centers in the area and are internationally recognized for their expertise.

Multiple myeloma treatment
Walter Lab

Myelodysplastic syndromes (MDS)

At Siteman, world-class physicians and nurses provide the best care possible for MDS. From our active clinical trials to our renowned Blood and Marrow Transplant Program, we will draw upon all of the treatments and resources currently available to help you.

MDS treatment

How is cellular therapy used in patient care at the Blood Cancer Center?

Every patient has an individualized treatment plan and multiple specialists who decide which interventions will be the best approach based on their specific case. The Blood Cancer Center treats patients with one or more cellular therapy including: 

Stem cell transplant

Stem cell transplant

Stem cell, or bone marrow, transplants are the oldest form of cellular therapy, and WashU Medicine physicians have been performing them at Barnes-Jewish Hospital for nearly 40 years.

Learn more

Request an Appointment

Fill out this form and our Patient Care Coordination Center will contact you to schedule an appointment.

Request an Appointment

Siteman’s Legacy

The Blood Cancer Center is anchored by Siteman’s nationally renowned stem cell transplant program that began in 1982. Over 40 years, we have expanded, performing over 10,000 stem cell transplants and innovating new approaches to treatment.  

Our legacy of discovery continues. Today Siteman holds a Specialized Program in Research Excellence (SPORE) in leukemia, a grant awarded by the National Cancer Institute. Our SPORE recognizes Siteman’s research abilities and accelerates them, bringing breakthroughs to patients’ bedsides. Siteman is one of the few cancer centers in the U.S. to hold multiple SPORE grants. 

Learn about Siteman’s SPORE in Leukemia.